Reddy announced as recipient of AAPS Global Leader Award
Samba Reddy, PhD, RPh, professor in the Department of Neurosciences and Experimental Therapeutics at the Texas A&M University College of Medicine, has been announced as the recipient of the 2020 American Association of Pharmaceutical Scientists (AAPS) Global Leader Award.
Founded in 1986, the AAPS is a world renowned professional, scientific organization that advances the pharmaceutical sciences by developing products and therapies for the betterment of public health. The AAPS includes approximately 7,000 individual members and more than 10,000 stakeholders working in academia, industry, government and other pharmaceutical science research institutes.
A board-certified pharmacist-pharmacologist, Reddy has continually pioneered research for neurotherapeutics, epilepsy and related brain disorders throughout his career. The National Institutes of Health (NIH) has funded his research for more than 14 years. Reddy is a Fellow of the American Epilepsy Society (AES), the American Association for the Advancement of Science and the American Association of Pharmaceutical Scientists.
Reddy has previously been a recipient of The Association of Former Students’ Distinguished Achievement Award in the category of research, the Lifetime Achievement Award at the 2020 Association of Biotechnology and Pharmacy (ABAP) & International Biotechnology Conference, and the Mario Toppo Distinguished Science Award, among many others.
This AAPS award honors Reddy’s lifetime research and leadership contributions to the global pharmaceutical sciences community. This award is one of the top honors given to one individual annually, and it recognizes leaders working in pharmaceutical science, technology, engineering or education who have made significant contributions.
The AAPS will celebrate Reddy’s honor at its Annual Meeting Awards Night during the AAPS PharmSci-360 meeting on October 26. The association will host a virtual reception in his honor.
“My congratulations go out to Dr. Reddy on this significant award,” said Amy Waer, MD, FACS, interim dean of the College of Medicine. “His research is doing great things in the treatment of epilepsy and other brain disorders and we are proud to have him in our college.”